Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma

被引：7
|
作者：
Halm, Ulrich [1 ]
机构：
[1] Pk Krankenhaus Leipzig, Leipzig, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 35期
关键词：
D O I：
10.1200/JCO.2006.08.4798
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5610 / 5610
页数：1
相关论文
共 50 条
  • [1] Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma
    Ferrone, Cristina R.
    Finkelstein, Dianne M.
    Thayer, Sarah P.
    Muzikansky, Alona
    Fernandez-del Castillo, Carlos
    Warshaw, Andrew L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2897 - 2902
  • [2] Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma - Reply
    Fernandez-del Castillo, Carlos
    Ferrone, Cristina R.
    Warshaw, Andrew L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (35) : 5611 - 5611
  • [3] Peri operative CA19-9 levels can predict stage and survival in patients resected for pancreatic adenocarcinoma
    Ferrone, CR
    Thayer, SP
    Finkelstein, DM
    Muzikansky, A
    Warshaw, AL
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 38 - 39
  • [4] Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
    Kim, Young Choon
    Kim, Hong Joo
    Park, Jung Ho
    Park, Dong Il
    Cho, Yong Kyun
    Sohn, Chong Il
    Jeon, Woo Kyu
    Kim, Byung Ik
    Shin, Jun Ho
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (12) : 1869 - 1875
  • [5] Undetectable preoperative levels of serum CA19-9 correlate with improved survival in patients with resectable pancreatic adenocarcinoma
    Berger, AC
    Meszoely, IM
    Watson, JC
    Ross, E
    Hoffman, JP
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : S72 - S72
  • [6] Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
    Wang, Jun-Ke
    Hu, Hai-Jie
    Shrestha, Anuj
    Ma, Wen-Jie
    Yang, Qin
    Liu, Fei
    Cheng, Nan-Sheng
    Li, Fu-Yu
    [J]. ONCOTARGET, 2017, 8 (28) : 45335 - 45344
  • [7] Initial CA19-9 levels predict survival in patients with carcinoma of the pancreatic head, but not resectability
    Watson, J. C.
    Hoffman, J. P.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S62 - S62
  • [8] Preoperative CA19-9 levels predict disease-free survival and overall survival in pancreatic adenocarcinoma patients after resection
    Guan, Shasha
    Chen, Yang
    Han, Quanli
    Deng, Guochao
    Wang, Yanrong
    Shi, Yan
    Dai, Guanghai
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 (03) : 811 - +
  • [9] Preoperative corrected CA19-9 levels predict survival of patients with resected pancreatic cancer
    Wang, Wei-Yi
    Pang, Wen-Jing
    Chen, Ping
    Su, Xiao
    Ben, Qi-Wen
    Yuan, Yao-Zong
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 3389 - 3397
  • [10] Assessment of Serum Neopterin, TPS and CA19-9 Levels in Patients With Pancreatic Adenocarcinoma
    Talar-Wojnarowska, R.
    Gasiorowska, A.
    Olakowski, M.
    Lekstan, A.
    Lampe, P.
    Smolarz, B.
    Romanowicz-Makowska, H.
    Kulig, A.
    Malecka-Panas, E.
    [J]. PANCREAS, 2009, 38 (08) : 1054 - 1055
12345